Zobrazeno 1 - 10
of 406
pro vyhledávání: '"V A, Shestakov"'
Autor:
A. Kh. Amandusova, A. E. Kovalenko, A. V. Morozov, K. R. Savelyeva, T. L. Batalova, O. A. Ostapyuk, L. V. Persanova, T. Yu. Andreevicheva, A. G. Beniashvili, V. N. Shestakov, S. V. Polyakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 2, Pp 95-102 (2023)
Introduction. Etoricoxib is a selective cyclooxygenase (COX-2) inhibitor used for the treatment of acute pain and has anti-inflammatory and analgesic efficacy. Etoricoxib causes fewer complications compared to other non-steroidal anti-inflammatory dr
Externí odkaz:
https://doaj.org/article/2ad4e1e393d04558be52a584df229d31
Publikováno v:
Научный вестник МГТУ ГА, Vol 25, Iss 6, Pp 53-61 (2023)
The development of modern gas turbine engineering imposes increasingly high requirements for the properties of the alloys used, associated with an increase in gas temperature before the turbine. However, the applicable nickel alloys have low heat res
Externí odkaz:
https://doaj.org/article/e3ce4de63029421cb07fd8a7081f2dbc
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 4, Pp 191-196 (2021)
Introduction. The article is devoted to the aspects of improving methodological approaches to the creation of a pharmaceutical quality system (PQS) at enterprises for the production of medicines, taking into account the possibility of using tools and
Externí odkaz:
https://doaj.org/article/1dbefe8cdb1d4cdcaf05bd82e7ac4e56
Autor:
A. I. Selezneva, V. A. Smirnov, V. V. Goryachkin, N. N. Chadova, S. V. Polyakov, V. N. Shestakov, R. A. Abramovich
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 3, Pp 148-165 (2021)
Introduction. The publication is devoted to the role of laboratory research in ensuring the quality of domestic medicines and is a review and analysis of regulatory documents and current publications on this topic.Text. A number of different types of
Externí odkaz:
https://doaj.org/article/05b0d3f9eb0b4735965d8bb6034db865
Autor:
A. P. Meshkovskiy, V. V. Beregovykh, V. N. Shestakov, N. V. Pyatigorskaya, Zh. I. Aladysheva, N. S. Nikolenko, A. M. Pyatigorskiy, E. I. Nesterkina
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 3, Pp 138-146 (2021)
Introduction. The article discusses significant changes in the procedure for pharmaceutical inspection of drug manufacturers for compliance with the requirements of the rules of good manufacturing practice (GMP) of the Eurasian Economic Union (EAEU),
Externí odkaz:
https://doaj.org/article/2d0217817a3342cc80fbb8969d1fb66a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 136-141 (2021)
Introduction. The publication is devoted to the topical organizational and personnel issues of the implementation of the pharmaceutical quality system (PQS). The relevance of the study is due to the high importance of quality assurance in the develop
Externí odkaz:
https://doaj.org/article/38439d3203d540879a9b91689e1208fd
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 130-135 (2021)
Introduction. The publication discusses the state and problems of personnel retraining in the implementation of the pharmaceutical quality system at pharmaceutical enter-prises of the Eurasian Union (EU) countries.Aim. The aim of the study is to comp
Externí odkaz:
https://doaj.org/article/66631cf280a54c75b6a53c70e31172af
Autor:
A. Kh. Amandusova, K. R. Saveleva, A. V. Morozov, V. A. Shelekhova, L. V. Persanova, S. V. Polyakov, V. N. Shestakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 4, Pp 136-140 (2020)
Introduction. This review describes the physicochemical properties that determine the use of hyaluronic acid in ophthalmology. We have studied methods for determining hyaluronic acid using various analytical methods.Text. Hyaluronic acid is a high mo
Externí odkaz:
https://doaj.org/article/2d5e3343a70d4aabbe5672f85cebb391
Autor:
V. N. Shestakov, Yu. V. Podpruzhnikov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 3, Pp 189-202 (2020)
Introduction. This paper is devoted to analysis of a new risk-based regulatory approach to the classification of deficiencies found by inspections of medicines manufacturers, which is undoubtedly relevant.Text. The article describes the new definitio
Externí odkaz:
https://doaj.org/article/a288384f9059424e94f137a76895376c
Autor:
V. A. Orlov, V. N. Shestakov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 2, Pp 151-158 (2020)
Introduction. One of the key issues in the field of assessing the conformity of drug manufacturers with the requirements of good manufacturing practice (GMP) is a systematic methodology for classifying revealed deficiencies (deviations, non-conformit
Externí odkaz:
https://doaj.org/article/ca10a68187354b89a1be7474c883a9d7